We are live on ! Find out more
PTPI

Petros Pharmaceuticals

Delisted

PTPI was delisted on the 21st of May, 2025.

Fund managers haven’t disclosed any holdings of PTPI yet.

PTPI Hedge Fund Activity: Q2 2025 in Review

0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q2 2025, worth a combined $0 — down 100% from $77.6K a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of PTPI and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Jane Street, exiting entirely with an estimated $38.9K sold.

  • 0 institutional investors held Petros Pharmaceuticals (PTPI) as of Q2 2025, down from 14 in Q1 2025.
  • Funds reported $0 of Petros Pharmaceuticals stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Petros Pharmaceuticals positions in Q2 2025 and 14 closed out, a net change of -14 holders.
  • The largest Petros Pharmaceuticals seller in Q2 2025 was Jane Street, an estimated $38.9K sold.

Based on aggregated 13F filings for Q2 2025.